Ashley Craddock
Family · Horn Lake, MSNPI 1851780597
Payments from drug & device makers
Across 126 payments — averaging $25.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$696
- Sumitomo Pharma America, Inc.$694
- Antares Pharma, Inc.$235
- Dendreon Pharmaceuticals LLC$200
- Johnson & Johnson$168
- Endo USA, Inc.$113
- plus $1K from 19 others
What the payments were for
- Travel & lodging$2939%
- Food & beverage$2,74987%
- Education$1214%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 9 | $696 |
| Sumitomo Pharma America, Inc. | 33 | $694 |
| Antares Pharma, Inc. | 12 | $235 |
| Dendreon Pharmaceuticals LLC | 6 | $200 |
| Johnson & Johnson | 5 | $168 |
| Endo USA, Inc. | 6 | $113 |
| Astellas Pharma US Inc | 5 | $103 |
| Coloplast | 5 | $98 |
| AbbVie | 5 | $94 |
| Tolmar Pharmaceuticals, Inc. | 5 | $93 |
| Tolmar, Inc. | 4 | $78 |
| Endo Pharmaceuticals Inc. | 4 | $74 |
| Myovant Sciences Inc. | 3 | $71 |
| Hollister Incorporated | 3 | $62 |
| Clarus Therapeutics Inc. | 5 | $59 |
| Urogen Pharma, Inc. | 1 | $49 |
| Urovant Sciences Inc | 3 | $45 |
| Halozyme Inc | 2 | $45 |
| Pfizer | 2 | $38 |
| Boston Scientific | 2 | $37 |
| Bayer | 2 | $34 |
| Ferring Pharmaceuticals Inc. | 1 | $28 |
| AstraZeneca | 1 | $20 |
| Verity Pharmaceuticals Inc. | 1 | $15 |
| Procept Biorobotics Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$249
How this compares
$3,163 in reported general payments places this provider in the 85th percentile of 3,007 family providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 239 | $154,422 |
| MyrbetriqMirabegron | 201 | $127,613 |
| Solifenacin Succinate | 139 | $8,655 |
| Tamsulosin Hcl | 681 | $8,314 |
| Estradiol | 54 | $3,409 |
| CefuroximeCefuroxime Axetil | 135 | $2,579 |
| Testosterone | 23 | $2,178 |
| Silodosin | 31 | $2,176 |
| Oxybutynin Chloride ErOxybutynin Chloride | 118 | $1,981 |
| Dutasteride | 34 | $1,675 |
| Terazosin Hcl | 81 | $1,476 |
| Testosterone Cypionate | 34 | $1,280 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 50 | $1,258 |
| Finasteride | 131 | $1,217 |
| Methenamine Hippurate | 16 | $1,183 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $694 | $154,422239 claims |
| Astellas Pharma US IncMyrbetriq | $103 | $127,613201 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,007 family providers in Mississippi.
Other family in Horn Lake
- Carrie WorshamHorn Lake$15K
- Cinda PerrymanFayette$888K
- Dodie McGeeRaymond$772K
- Gina BurgeJackson$237K
- Christy DavisJackson$208K
- Maranda EversollFlowood$197K
- Dana DelaskiJackson$158K
- Kristin CarrollJackson$158K
- Shannon FryeryOxford$127K
- Nativel CollinsMantachie$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.